Bioactive Peptide Market Share To Exhibit a CAGR of 9.4% By 2026, Owing to Increasing Launch of New Products
Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Global Bioactive Peptide Market, by Source (Plant, Milk, Eggs, Meat, Fish and Others), By Therapeutic Area (Antihypertensive, Antioxidant, Immunostimulatory, Antimicrobial, Diabetes, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), published by Coherent Market Insights, the global bioactive peptide market was valued at US$ 3,265.2 million in 2017, and is projected to exhibit a CAGR of 9.4% over the forecast period (2018–2026).
Request FREE Sample
Bioactive peptides are used in dietary supplements, pharmaceuticals, and novel food supplements, whereas collagen peptides are used in sports and active nutrition products to enhance the performance of athletes.
Increasing launch of new products is expected to propel growth of the global bioactive peptide market over the forecast period. For instance, in March 2019, Gelita launched collagen peptide, for use in a variety of functional and nutritional beverages. Moreover, R&D in bioactive peptides is also expected to aid in growth of the market. For instance, in February 2017, researchers from Massachusetts Institute of Technology (MIT), reported development of a new tabletop machine that can rapidly produce large quantities of customized peptides. Similarly, in July 2017, a Nature-published research reported development of a synthetic peptide that can specifically inhibit Zika virus infection.
To know the latest trends and insights prevalent in the global bioactive peptide market PRESS RELEASE, click the link below: https://www.coherentmarketinsights.com/press-release/bioactive-peptide-market-to-surpass-us-73358-mn-by-2026-2473
Among source, the plant segment is expected to hold dominant position in the global bioactive peptide market over the forecast period.
Among therapeutic area, the antihypertensive segment is expected to hold dominant position in the global bioactive peptide market over the forecast period, owing to high incidence of cardiovascular diseases.
Major players in the market are focused on adopting partnership strategies to expand their product portfolio. For instance, in July 2019, Nuritas partnered with Stonehaven Incubate for the development of advanced animal health solutions, with an initial focus on animal feed ingredient.
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3018
- The global bioactive peptide market is expected to exhibit a CAGR of 9.4% over the forecast period
- Major players operating in the global bioactive peptide market include Archer Daniels Midland Company, Seagarden AS, Phermpep Co. Ltd., Arlak Biotech Pvt. Ltd., Naturade, Royal DSM, MYOS RENS Technology Inc., Natural Factors Inc., and Valio Oy
Other Related Reports:
Herceptin Biosimilar Market, by Indication (Breast Cancer, Gastric Cancer, and Others), By Distribution Channel (Hospital, Oncology Centers, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027
Pediatric Palliative Care Drugs Market, By Drug Class (Analgesics, Anti‐emetics, Laxatives, Adjuvant Medications, Steroids, Sedatives, Neuroleptic Medications, and Others), By Route of Administration (Oral, Topical, and Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share Outlook, and Opportunity Analysis, 2020 – 2027
Interferon Beta Drugs Market, by Product Type (Interferon Beta-1A, Interferon Beta-1B, and Peginterferon Beta-1A), By Route of Administration (Intramuscular, Subcutaneous, and Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at firstname.lastname@example.org.
- CDN Newswire